Comparison of an agonist, urocortin, and an antagonist, astressin, as radioligands for characterization of corticotropin-releasing factor receptors

Journal of Pharmacology and Experimental Therapeutics

Volumn 288, Issue 2, 1999, Pages 729-734

  Perrin, Marilyn H ^a   Sutton, Steve W ^a   Cervini, Laura A ^a   Rivier, Jean E ^a   Vale, Wylie W ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASTRESSIN; BRAIN RECEPTOR; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR RECEPTOR; CORTICOTROPIN RELEASING FACTOR[9-41]; GUANINE NUCLEOTIDE; GUANINE NUCLEOTIDE BINDING PROTEIN; RADIOLIGAND; SAUVAGINE; UNCLASSIFIED DRUG; UROCORTIN; UROTENSIN I;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BRAIN STEM; CEREBELLUM; CHO CELL; CONTROLLED STUDY; DRUG BINDING SITE; DRUG POTENCY; DRUG RECEPTOR BINDING; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CHO CELLS; CORTICOTROPIN-RELEASING HORMONE; CRICETINAE; GUANINE NUCLEOTIDES; NEUROPROTECTIVE AGENTS; PEPTIDE FRAGMENTS; RADIOLIGAND ASSAY; RATS; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE;

EID: 0033020807     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Becker A, Haendler B, Hechler U and Schleuning W-D (1994) Mutational analysis of human endothelin receptors ETA and ETB. Identification of regions involved in the selectivity for endothelin 3 or cyclo-(D-Trp-D-Ast-Pro-D-Val-Leu). FEBS Lett 221:951-958.
2. Brown EM, Fedak SA, Woodard CJ, Aurbach GD and Rodbard D (1976) β-Adrenergic receptor interactions. J Biol Chem 251:1239-1246.
3. Chalmers DT, Lovenberg TW and De Souza EB (1995) Localization of novel corticotropin-releasing factor receptor (CRF2)mRNA expression to specific subcortical nuclei in rat brain: Comparison with CRF1 receptor mRNA expression. J Neurosci 15:6340-6350.
4. Chang C-P, Pearse IRV, O'Connell S, and Rosenfeld MG (1993) Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain. Neuron 11:1187-1195.
5. Chen R, Lewis KA, Perrin MH and Vale WW (1993) Expression cloning of a human corticotropin-releasing factor receptor. Proc Natl Acad Sci USA 90:8967-8971.
6. Conklin BR and Bourne HR (1993) Structural elements of Gα subunits that interact with Gβγ, receptors and effectors. Cell 73:631-641.
7. DeLean A, Stadel JM and Lefkovritz RJ (1980) A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled β-adrenergic receptor. J Biol Chem 255:7108-7117.
8. De Souza EB, Perrin MH, Insel TR, Rivier J, Vale WW and Kuhar MJ (1984) Corticotropin-releasing factor receptors in rat forebrain: Autoradiographic identification. Science 224:1449-1451.
9. Donaldson CJ, Sutton SW, Perrin MH, Corrigan AZ, Lewis KA, Rivier JE, Vaughan JM and Vale WW (1996) Cloning and characterization of human urocortin. Endocrinology 137:2167-2170.
10. Gether U, Johansen TE, Snider RM, Lowe JA III, Nakanishi S and Schwartz TW (1993) Different binding epitopes on the NK1 receptor for substance P and a non-peptide antagonist. Nature 362:345-348.
11. Gottowick J, Goetschy B, Henriot S, Kitas E, Fluhman B, Clerc RG, Moriau JL, Monsma FJ and Kilpatrick GJ (1997) Labelling of CRF1 and CRF2 receptors using the novel radioligand, [3H]-urocortin. Neuropharmacology 36:1439-1446.
12. Grigoriadis DE and De Souza EB (1988) The brain corticotropin-releasing factor (CRF) receptor is of lower apparent molecular weight than the CRF receptor in anterior pituitary. J Biol Chem 263:10927-10931.
13. Grigoriadis DE and De Souza EB (1989) Heterogeneity between brain and pituitary corticotropin-releasing factor receptors is due to differential glycosylation. Endocrinology 125:1877-1888.
14. Gulyas J, Rivier C, Perrin M, Koerber SC, Sutton S, Corrigan A, Lahrichi SL, Craig AG, Vale W and Rivier J (1995) Potent, structurally constrained agonists and competitive antagonists of corticotropin-releasing factor. Proc Natl Acad Sci USA 92:10575-10579.
15. Hoeger C, Galyean R, Boublik J, McClintock R and Rivier J (1987) Preparative reversed phase high performance liquid chromatography. II. Effects of buffer pH on the purification of synthetic peptides. Biochromatography 2:134-142.
16. Kenakin T (1997) Differences between natural and recombinant G-protein-coupled receptor systems with varying receptor/G protein stoichiometry. Trends Pharmacol Sci 18:456-464.
17. Kishimoto A, Nishiyama K, Nakanishi H, Uratsuji Y, Nomura H, Takeyama Y and Nishizuka Y (1985) Studies on the phosphorylation of myelin basic protein by protein kinase C and adenosine 3′:5′-monophosphate-dependent protein kinase. J Biol Chem 260:12492-12499.
18. Kishimoto T, Pearse RV II, Lin CR and Rosenfeld MG (1995) A sauvagine/ corticotropin-releasing factor receptor expressed in heart and skeletal muscle. Proc Natl Acad Sci USA 92:1108-1112.
19. Kostich WA, Chen A, Sperle K and Largent BL (1998) Molecular identification and analysis of a novel human corticotropin-releasing factor (CRF) receptor: The CRF2gamma receptor. Mol Endocrinol 12:1077-1085.
20. Lefkowitz RJ (1978) Identification and regulation of adrenergic receptors, in Psychopharmacology: A Generation of Progress (Lipton MA, DiCascio A, Killam KF eds), Raven Press, New York.
21. Lovenberg TW, Chen WL, Grigoriadis DE, Clevenger W, Chalmers DT, De Souza EB and Oltersdorf T (1995) Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc Natl Acad Sci USA 92:836-840.
22. Lynch CJ, Charest R, Blackmore PF and Exton JH (1985) Studies on the hepatic α1-adrenergic receptor. J Biol Chem 260:1593-1600.
23. Maguire ME, Ross EM, Gilman AG (1977) β-Adrenergic receptor: Ligand binding properties and interaction with adenylycyclase. Adv Cyclic Nucleotide Res 8:1-83.
24. Munson PJ and Rodbard D (1980) Ligand: A versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 107:220-239.
25. Perrin M, Donaldson C, Chen R, Blount A, Berggren T, Bilezikjian L, Sawchenko P and Vale W (1995) Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart. Proc Natl Acad Sci USA 92:2969-2973.
26. Perrin MH, Haas Y, Porter J, Rivier J and Vale W (1989) The gonadotropin-releasing hormone pituitary receptor interacts with a guanosine triphosphate binding protein: Differential effects of guanyl nucleotides on agonist and antagonist binding. Endocrinology 124:798-804.
27. Perrin MH, Haas Y, Rivier JE and Vale WW (1986) Corticotropin-releasing factor binding to the anterior pituitary receptor is modulated by divalent cations and guanyl nucleotides. Endocrinology 118:1171-1179.
28. Potter E, Sutton S, Donaldson C, Chen R, Perrin M, Lewis K, Sawchenko PE and Vale W (1994) Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary. Proc Natl Acad Sci USA 91:8777-8781.
29. Rominger DH, Rominger CM, Fitzgerald LW, Grzanna R, Largent BL and Zaczek R (1998) Characterization of [125I]sauvagine binding to CRH2 receptors: Membrane homogenate and autoradiographic studies. J Pharmacol Exp Ther 286:459-468.
30. Rosenkilde MM, Cahir M, Gether U, Hjorth SA and Schwartz TW (1994) Mutations along transmembrane segment II of the NK-1 receptor affect substance P competition with non-peptide antagonists but not substance P binding. J Biol Chem 269:28160-28164.
31. Sato M, Kataoka R, Dingus J, Wilcox M, Hildebrandt JD and Lanier SM (1995) Factors determining specificity of signal transduction by G-protein-coupled receptors. J Biol Chem 270:15269-15276.
32. Schwartz TW, Gether U, Schambye HT and Hjorth SA (1995) Molecular mechanism of action of non-peptide ligands for peptide receptors. Curr Pharmaceut Des 1:355-372.
33. Sleight AJ, Stam NJ, Mutel V and Vanderheyden PM (1996) Radiolabelling of the human 5-HT2: A receptor with an agonist, a partial agonist and an antagonist: Effects on apparent agonist affinities. Biochem Pharmacol 51:71-76.
34. Smith GW, Aubry J-M, Delhu F, Contarino LM, Bilezikjian LM, Gold L, Chen R, Marchuk Y, Hauser C, Koob G, Vale W and Lee K-F (1998) Corticotropin releasing factor receptor 1 deficient mice display decreased anxiety, an impaired stress response and aberrant development of the neuroendocrine system. Neuron 20:1-20.
35. Stenzel P, Kesterson R, Yeung W, Cone RD, Rittenberg MB and Stenzel-Poore MP (1995) Identification of a novel murine receptor for eorticotropin-releasing hormone expressed in the heart. Mol Endocrinol 9:637-645.
36. Sutton SW, Behan DP, Lahrichi SL, Kaiser R, Corrigan A, Lowry P, Potter E, Rivier J and Vale W (1995) Ligand requirements of the human corticotropin releasing factor binding protein. Endocrinology 136:1097-1102.
37. Turnbull AV, Vale W and Rivier C (1996) Urocortin, a corticotropin-releasing factor-related mammalian peptide, inhibits edema due to thermal injury in rats. Eur J Pharmacol 303:213-216.
38. Vaughan J, Donaldson C, Bittencourt J, Perrin MH, Lewis K, Sutton S, Chan R, Turnbull AV, Lovejoy D, Rivier C, Rivier J, Sawchenko PE and Vale W (1995) Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 378:287-292.
39. Vita N, Laurent P, Lefort S, Chalon P, Lelias J-M, Kaghad M, Le Fur G, Caput D and Ferrara P (1993) Primary structure and functional expression of mouse pituitary and human brain corticotrophin releasing factor receptors. FEBS Lett 335:1-5.
40. Webster WL, Lewis DB, Torpy DJ, Zachman EK, Rice KC and Chrousos GP (1996) In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: Suppression of pituitary ACTH release and peripheral inflammation. Endocrinology 137:5747-5750.